The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial

F Dastan, H Jamaati, S Barati, S Varmazyar… - Frontiers in …, 2023 - frontiersin.org
Background: Tocilizumab and baricitinib are considered standard treatments for hospitalized
COVID-19 patients with an inflammatory status. However, the effects of co-administering …

Green electrochemical sensor based on ZnO@ α-Fe2O3 NPs modified carbon paste electrode for sensitive voltammetric determination of the FDA-approved Anti …

MB Ali, AM Abdel-Raoof, S Morshedy, EA Matter… - Sustainable Chemistry …, 2024 - Elsevier
In this study, we developed an electrochemical sensor for the sensitive voltammetric
determination of Baricitinib (BCT), a recently FDA-approved medication for curing COVID …

Recent Trends and Possible Future Trajectory of COVID‐19

I Adams, O Adi‐Dako, E Boafo, EK Ofori… - Rising Contagious …, 2024 - Wiley Online Library
Originating as an outbreak in Wuhan, China, coronavirus disease 2019 (COVID‐19) spread
to several countries. It later became a global health crisis, leading to millions of deaths …

Repurposing Kinase Inhibitors for COVID-19 A Comprehensive Review of Antiviral and Immunomodulatory Effects

R Bhat, G Palakki, M Uday, V Karicheri… - International Journal of …, 2024 - ijphi.com
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has posed significant global
challenges, impacting millions and straining healthcare systems. With over 600 million …

[HTML][HTML] ДИНАМИКА КЛИНИКО-ИММУНОЛОГИЧЕСКИХ ПОКАЗАТЕЛЕЙ У ПАЦИЕНТОВ, ПЕРЕНЕСШИХ COVID-19 СРЕДНЕТЯЖЕЛОГО ТЕЧЕНИЯ И …

ЛП Сизякина, НА Скрипкина, ЕА Антонова… - …, 2023 - cyberleninka.ru
Введение. Исследование патогенеза коронавирусной инфекции COVID-19 остается
одной из главных задач современной науки. Изучив механизмы развития заболевания …